Segment disclosures

Company overview

Markel Corporation

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

110 dimension combinations 768 retained observations 21 reported periods Partial retained history

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Disposition Gain · Markel Ventures

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:DispositionGainMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-300 USD20231101Open filing evidence
2023-01-01 – 2023-03-310 USD20230426Open filing evidence
2022-01-01 – 2022-09-300 USD20231101Open filing evidence
2022-01-01 – 2022-03-310 USD20230426Open filing evidence

Disposition Gain · Markel Ventures Operations

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:DispositionGainMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-06-300 USD20220802Open filing evidence

Disposition Gain · Other

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:DispositionGainMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-09-3016923000 USD20231101Open filing evidence
2023-04-01 – 2023-06-3016923000 USD20230802Open filing evidence
2023-01-01 – 2023-06-3016923000 USD20230802Open filing evidence
2023-01-01 – 2023-03-310 USD20230426Open filing evidence
2022-01-01 – 2022-12-31225828000 USD20230217Open filing evidence
2022-01-01 – 2022-09-30107293000 USD20231101Open filing evidence
2022-04-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-06-30107293000 USD20230802Open filing evidence
2022-01-01 – 2022-03-31107293000 USD20230426Open filing evidence
2021-01-01 – 2021-12-310 USD20230217Open filing evidence
2021-01-01 – 2021-09-300 USD20221101Open filing evidence

Investment Management · Revenue From Contract With Customer · Markel Ventures

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-310 USD20240501Open filing evidence
2023-01-01 – 2023-03-310 USD20240501Open filing evidence

Investment Management · Revenue From Contract With Customer · Markel Ventures Operations

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-300 USD20221101Open filing evidence
2022-01-01 – 2022-09-300 USD20221101Open filing evidence
2021-07-01 – 2021-09-300 USD20221101Open filing evidence
2021-01-01 – 2021-09-300 USD20221101Open filing evidence

Investment Management · Revenue From Contract With Customer · Other Insurance Operations

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3119936000 USD20240501Open filing evidence
2023-01-01 – 2023-03-3110459000 USD20240501Open filing evidence

Investment Management · Revenue From Contract With Customer · Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-3110459000 USD20230426Open filing evidence
2022-07-01 – 2022-09-3015641000 USD20221101Open filing evidence
2022-01-01 – 2022-09-3055197000 USD20221101Open filing evidence
2022-01-01 – 2022-03-3119228000 USD20230426Open filing evidence
2021-07-01 – 2021-09-3020571000 USD20221101Open filing evidence
2021-01-01 – 2021-09-3057693000 USD20221101Open filing evidence

Investment Management · Markel Ventures Operations · Revenue From Contract With Customer

Product Or Service · Statement Business Segments · Concentration Risk By Benchmark

Source dimensions srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-310 USD20220426Open filing evidence

Management Fees · Revenue From Contract With Customer · Consumer And Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Management Fees · Revenue From Contract With Customer · Corporate Operations

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Management Fees · Revenue From Contract With Customer · Financial

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3037658000 USD20260729Open filing evidence
2026-01-01 – 2026-06-3079212000 USD20260729Open filing evidence
2026-01-01 – 2026-03-3141554000 USD20260428Open filing evidence
2025-01-01 – 2025-12-31161890000 USD20260226Open filing evidence
2025-07-01 – 2025-09-3030340000 USD20251029Open filing evidence
2025-01-01 – 2025-09-3085790000 USD20251029Open filing evidence
2025-04-01 – 2025-06-3029582000 USD20260729Open filing evidence
2025-01-01 – 2025-06-3055450000 USD20260729Open filing evidence
2025-01-01 – 2025-03-3125868000 USD20260428Open filing evidence
2024-01-01 – 2024-12-3197226000 USD20260226Open filing evidence
2024-07-01 – 2024-09-3025858000 USD20251029Open filing evidence
2024-01-01 – 2024-09-3068340000 USD20251029Open filing evidence
2023-01-01 – 2023-12-3199509000 USD20260226Open filing evidence

Management Fees · Revenue From Contract With Customer · Industrial

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Management Fees · Revenue From Contract With Customer · Markel Insurance

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Management Fees · Revenue From Contract With Customer · Markel Ventures

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-300 USD20250730Open filing evidence
2025-01-01 – 2025-06-300 USD20250730Open filing evidence
2025-01-01 – 2025-03-310 USD20250430Open filing evidence
2024-01-01 – 2024-12-310 USD20250224Open filing evidence
2024-07-01 – 2024-09-300 USD20241030Open filing evidence
2024-01-01 – 2024-09-300 USD20241030Open filing evidence
2024-04-01 – 2024-06-300 USD20250730Open filing evidence
2024-01-01 – 2024-06-300 USD20250730Open filing evidence
2024-01-01 – 2024-03-310 USD20250430Open filing evidence
2023-01-01 – 2023-12-310 USD20250224Open filing evidence
2023-07-01 – 2023-09-300 USD20241030Open filing evidence
2023-01-01 – 2023-09-300 USD20241030Open filing evidence
2022-01-01 – 2022-12-310 USD20250224Open filing evidence

Management Fees · Revenue From Contract With Customer · Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ManagementFeesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-3029582000 USD20250730Open filing evidence
2025-01-01 – 2025-06-3055450000 USD20250730Open filing evidence
2025-01-01 – 2025-03-3125868000 USD20250430Open filing evidence
2024-01-01 – 2024-12-3197226000 USD20250224Open filing evidence
2024-07-01 – 2024-09-3025858000 USD20241030Open filing evidence
2024-01-01 – 2024-09-3068340000 USD20241030Open filing evidence
2024-04-01 – 2024-06-3022546000 USD20250730Open filing evidence
2024-01-01 – 2024-06-3042482000 USD20250730Open filing evidence
2024-01-01 – 2024-03-3119936000 USD20250430Open filing evidence
2023-01-01 – 2023-12-3199509000 USD20250224Open filing evidence
2023-07-01 – 2023-09-3044204000 USD20241030Open filing evidence
2023-01-01 – 2023-09-3076108000 USD20241030Open filing evidence
2022-01-01 – 2022-12-3179209000 USD20250224Open filing evidence

Other Revenues · Markel Ventures Operations

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:OtherRevenuesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-3025950000 USD20221101Open filing evidence
2022-01-01 – 2022-09-3084800000 USD20221101Open filing evidence
2022-04-01 – 2022-06-3027370000 USD20220802Open filing evidence
2022-01-01 – 2022-06-3058850000 USD20220802Open filing evidence
2021-01-01 – 2021-09-3082824000 USD20221101Open filing evidence

Other Revenues · Other

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:OtherRevenuesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-31658000 USD20230426Open filing evidence
2022-07-01 – 2022-09-30118000 USD20221101Open filing evidence
2022-01-01 – 2022-09-30724000 USD20221101Open filing evidence
2022-04-01 – 2022-06-30281000 USD20220802Open filing evidence
2022-01-01 – 2022-06-30606000 USD20220802Open filing evidence
2022-01-01 – 2022-03-317001000 RestatedUSD20230426Open filing evidence

Program Services And Other Fronting · Markel Ventures

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-300 USD20231101Open filing evidence
2023-01-01 – 2023-09-300 USD20231101Open filing evidence
2022-07-01 – 2022-09-300 USD20231101Open filing evidence
2022-01-01 – 2022-09-300 USD20231101Open filing evidence

Program Services And Other Fronting · Markel Ventures Operations

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-300 USD20220802Open filing evidence
2022-01-01 – 2022-06-300 USD20220802Open filing evidence

Program Services And Other Fronting · Other

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3039499000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30105952000 USD20231101Open filing evidence
2023-01-01 – 2023-03-3128890000 USD20230426Open filing evidence
2022-07-01 – 2022-09-3040033000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30103096000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3029731000 USD20220802Open filing evidence
2022-01-01 – 2022-06-3063063000 USD20220802Open filing evidence
2022-01-01 – 2022-03-3133332000 USD20230426Open filing evidence

Program Servicesand Other · Markel Ventures Operations

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ProgramServicesandOtherMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-310 USD20220218Open filing evidence

Program Servicesand Other · Other

Product Or Service · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ProgramServicesandOtherMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31123823000 USD20220218Open filing evidence

Services · Revenue From Contract With Customer · Consumer And Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-3095562000 USD20260729Open filing evidence
2026-01-01 – 2026-06-30182920000 USD20260729Open filing evidence
2026-01-01 – 2026-03-3187358000 USD20260428Open filing evidence
2025-01-01 – 2025-12-31353403000 USD20260226Open filing evidence
2025-07-01 – 2025-09-3091598000 USD20251029Open filing evidence
2025-01-01 – 2025-09-30258732000 USD20251029Open filing evidence
2025-04-01 – 2025-06-3088693000 USD20260729Open filing evidence
2025-01-01 – 2025-06-30167134000 USD20260729Open filing evidence
2025-01-01 – 2025-03-3178441000 USD20260428Open filing evidence
2024-01-01 – 2024-12-31314439000 USD20260226Open filing evidence
2024-07-01 – 2024-09-3074977000 USD20251029Open filing evidence
2024-01-01 – 2024-09-30233874000 USD20251029Open filing evidence
2023-01-01 – 2023-12-31325703000 USD20260226Open filing evidence

Services · Revenue From Contract With Customer · Corporate Operations

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Services · Revenue From Contract With Customer · Financial

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30110000 USD20260729Open filing evidence
2026-01-01 – 2026-06-30370000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31260000 USD20260428Open filing evidence
2025-01-01 – 2025-12-311275000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30441000 USD20251029Open filing evidence
2025-01-01 – 2025-09-301160000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30249000 USD20260729Open filing evidence
2025-01-01 – 2025-06-30719000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31470000 USD20260428Open filing evidence
2024-01-01 – 2024-12-31828000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30-352000 USD20251029Open filing evidence
2024-01-01 – 2024-09-30476000 USD20251029Open filing evidence
2023-01-01 – 2023-12-31816000 USD20260226Open filing evidence

Services · Revenue From Contract With Customer · Industrial

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30585115000 USD20260729Open filing evidence
2026-01-01 – 2026-06-301042380000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31457265000 USD20260428Open filing evidence
2025-01-01 – 2025-12-312171322000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30588148000 USD20251029Open filing evidence
2025-01-01 – 2025-09-301578137000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30560095000 USD20260729Open filing evidence
2025-01-01 – 2025-06-30989989000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31429894000 USD20260428Open filing evidence
2024-01-01 – 2024-12-312001383000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30536085000 USD20251029Open filing evidence
2024-01-01 – 2024-09-301445797000 USD20251029Open filing evidence
2023-01-01 – 2023-12-311937158000 USD20260226Open filing evidence

Services · Revenue From Contract With Customer · Markel Insurance

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301581000 USD20260729Open filing evidence
2026-01-01 – 2026-06-303123000 USD20260729Open filing evidence
2026-01-01 – 2026-03-311542000 USD20260428Open filing evidence
2025-01-01 – 2025-12-3110521000 USD20260226Open filing evidence
2025-07-01 – 2025-09-301199000 USD20251029Open filing evidence
2025-01-01 – 2025-09-304748000 USD20251029Open filing evidence
2025-04-01 – 2025-06-301604000 USD20260729Open filing evidence
2025-01-01 – 2025-06-303549000 USD20260729Open filing evidence
2025-01-01 – 2025-03-311945000 USD20260428Open filing evidence
2024-01-01 – 2024-12-319365000 USD20260226Open filing evidence
2024-07-01 – 2024-09-302593000 USD20251029Open filing evidence
2024-01-01 – 2024-09-306313000 USD20251029Open filing evidence
2023-01-01 – 2023-12-319525000 USD20260226Open filing evidence

Services · Revenue From Contract With Customer · Markel Ventures

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-30648788000 USD20250730Open filing evidence
2025-01-01 – 2025-06-301157123000 USD20250730Open filing evidence
2025-01-01 – 2025-03-31508335000 USD20250430Open filing evidence
2024-01-01 – 2024-12-312315822000 USD20250224Open filing evidence
2024-07-01 – 2024-09-30611062000 USD20241030Open filing evidence
2024-01-01 – 2024-09-301679671000 USD20241030Open filing evidence
2024-04-01 – 2024-06-30570319000 USD20250730Open filing evidence
2024-01-01 – 2024-06-301068609000 USD20250730Open filing evidence
2024-01-01 – 2024-03-31498290000 USD20250430Open filing evidence
2023-01-01 – 2023-12-312262861000 USD20250224Open filing evidence
2023-07-01 – 2023-09-30595459000 USD20241030Open filing evidence
2023-01-01 – 2023-09-301651339000 USD20241030Open filing evidence
2022-01-01 – 2022-12-312184196000 USD20250224Open filing evidence

Services · Revenue From Contract With Customer · Markel Ventures Operations

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30614519000 USD20221101Open filing evidence
2022-01-01 – 2022-09-301633353000 USD20221101Open filing evidence
2022-04-01 – 2022-06-30569385000 USD20220802Open filing evidence
2022-01-01 – 2022-06-301018834000 USD20220802Open filing evidence

Services · Revenue From Contract With Customer · Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-301853000 USD20250730Open filing evidence
2025-01-01 – 2025-06-304268000 USD20250730Open filing evidence
2025-01-01 – 2025-03-312415000 USD20250430Open filing evidence
2024-01-01 – 2024-12-3110193000 USD20250224Open filing evidence
2024-07-01 – 2024-09-302241000 USD20241030Open filing evidence
2024-01-01 – 2024-09-306789000 USD20241030Open filing evidence
2024-04-01 – 2024-06-302415000 USD20250730Open filing evidence
2024-01-01 – 2024-06-304548000 USD20250730Open filing evidence
2024-01-01 – 2024-03-312133000 USD20250430Open filing evidence
2023-01-01 – 2023-12-3110341000 USD20250224Open filing evidence
2023-07-01 – 2023-09-302904000 USD20241030Open filing evidence
2023-01-01 – 2023-09-307542000 USD20241030Open filing evidence
2023-01-01 – 2023-03-312854000 USD20230426Open filing evidence
2022-01-01 – 2022-12-3143875000 USD20250224Open filing evidence
2022-07-01 – 2022-09-3011529000 USD20221101Open filing evidence
2022-01-01 – 2022-09-3041547000 USD20221101Open filing evidence
2022-04-01 – 2022-06-308450000 USD20220802Open filing evidence
2022-01-01 – 2022-06-3030018000 USD20220802Open filing evidence
2022-01-01 – 2022-03-3121568000 USD20230426Open filing evidence
2021-01-01 – 2021-12-31134850000 USD20240223Open filing evidence

Services · Markel Ventures · Revenue From Contract With Customer

Product Or Service · Statement Business Segments · Concentration Risk By Benchmark

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-312262861000 USD20240223Open filing evidence
2023-01-01 – 2023-03-31485662000 USD20230426Open filing evidence
2022-01-01 – 2022-12-312184196000 USD20240223Open filing evidence
2022-01-01 – 2022-03-31449449000 USD20230426Open filing evidence
2021-01-01 – 2021-12-311837029000 USD20240223Open filing evidence

Services · Markel Ventures Operations · Revenue From Contract With Customer

Product Or Service · Statement Business Segments · Concentration Risk By Benchmark

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-31449449000 USD20220426Open filing evidence

Services · Other · Revenue From Contract With Customer

Product Or Service · Statement Business Segments · Concentration Risk By Benchmark

Source dimensions srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-301784000 USD20230802Open filing evidence
2023-01-01 – 2023-06-304638000 USD20230802Open filing evidence
2022-04-01 – 2022-06-308450000 USD20230802Open filing evidence
2022-01-01 – 2022-06-3030018000 USD20230802Open filing evidence

Product · Revenue From Contract With Customer · Consumer And Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30437498000 USD20260729Open filing evidence
2026-01-01 – 2026-06-30612048000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31174550000 USD20260428Open filing evidence
2025-01-01 – 2025-12-31957885000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30181628000 USD20251029Open filing evidence
2025-01-01 – 2025-09-30795614000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30422226000 USD20260729Open filing evidence
2025-01-01 – 2025-06-30613986000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31191760000 USD20260428Open filing evidence
2024-01-01 – 2024-12-31944671000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30173351000 USD20251029Open filing evidence
2024-01-01 – 2024-09-30779035000 USD20251029Open filing evidence
2023-01-01 – 2023-12-31858332000 USD20260226Open filing evidence

Product · Revenue From Contract With Customer · Corporate Operations

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Product · Revenue From Contract With Customer · Financial

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Product · Revenue From Contract With Customer · Industrial

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30414462000 USD20260729Open filing evidence
2026-01-01 – 2026-06-30803950000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31389488000 USD20260428Open filing evidence
2025-01-01 – 2025-12-311591519000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30417986000 USD20251029Open filing evidence
2025-01-01 – 2025-09-301197798000 USD20251029Open filing evidence
2025-04-01 – 2025-06-30417455000 USD20260729Open filing evidence
2025-01-01 – 2025-06-30779812000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31362357000 USD20260428Open filing evidence
2024-01-01 – 2024-12-311662910000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30432120000 USD20251029Open filing evidence
2024-01-01 – 2024-09-301261664000 USD20251029Open filing evidence
2023-01-01 – 2023-12-311628722000 USD20260226Open filing evidence

Product · Revenue From Contract With Customer · Markel Insurance

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD20251029Open filing evidence
2025-01-01 – 2025-09-300 USD20251029Open filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Product · Revenue From Contract With Customer · Markel Ventures

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-30839681000 USD20250730Open filing evidence
2025-01-01 – 2025-06-301393798000 USD20250730Open filing evidence
2025-01-01 – 2025-03-31554117000 USD20250430Open filing evidence
2024-01-01 – 2024-12-312607581000 USD20250224Open filing evidence
2024-07-01 – 2024-09-30605471000 USD20241030Open filing evidence
2024-01-01 – 2024-09-302040699000 USD20241030Open filing evidence
2024-04-01 – 2024-06-30840636000 USD20250730Open filing evidence
2024-01-01 – 2024-06-301435228000 USD20250730Open filing evidence
2024-01-01 – 2024-03-31594592000 USD20250430Open filing evidence
2023-01-01 – 2023-12-312487054000 USD20250224Open filing evidence
2023-07-01 – 2023-09-30585707000 USD20241030Open filing evidence
2023-01-01 – 2023-09-301921773000 USD20241030Open filing evidence
2023-04-01 – 2023-06-30770171000 USD20240731Open filing evidence
2023-01-01 – 2023-06-301336066000 USD20240731Open filing evidence
2022-01-01 – 2022-12-312379399000 USD20250224Open filing evidence

Product · Revenue From Contract With Customer · Other

Product Or Service · Concentration Risk By Benchmark · Statement Business Segments

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-300 USD20250730Open filing evidence
2025-01-01 – 2025-06-300 USD20250730Open filing evidence
2025-01-01 – 2025-03-310 USD20250430Open filing evidence
2024-01-01 – 2024-12-310 USD20250224Open filing evidence
2024-07-01 – 2024-09-300 USD20241030Open filing evidence
2024-01-01 – 2024-09-300 USD20241030Open filing evidence
2024-04-01 – 2024-06-300 USD20250730Open filing evidence
2024-01-01 – 2024-06-300 USD20250730Open filing evidence
2024-01-01 – 2024-03-310 USD20250430Open filing evidence
2023-01-01 – 2023-12-310 USD20250224Open filing evidence
2023-07-01 – 2023-09-300 USD20241030Open filing evidence
2023-01-01 – 2023-09-300 USD20241030Open filing evidence
2023-04-01 – 2023-06-300 USD20240731Open filing evidence
2023-01-01 – 2023-06-300 USD20240731Open filing evidence
2022-01-01 – 2022-12-310 USD20250224Open filing evidence
2022-01-01 – 2022-03-310 USD20220426Open filing evidence

Product · Other · Revenue From Contract With Customer

Product Or Service · Statement Business Segments · Concentration Risk By Benchmark

Source dimensions srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-310 USD20230217Open filing evidence
2021-01-01 – 2021-12-310 USD20230217Open filing evidence

Revenue From Contract With Customer · Investment Management · Other

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-3022546000 USD20240731Open filing evidence
2024-01-01 – 2024-06-3042482000 USD20240731Open filing evidence
2023-01-01 – 2023-12-3199509000 USD20240223Open filing evidence
2023-04-01 – 2023-06-3021445000 USD20240731Open filing evidence
2023-01-01 – 2023-06-3031904000 USD20240731Open filing evidence
2022-01-01 – 2022-12-3179209000 USD20240223Open filing evidence
2021-01-01 – 2021-12-3186257000 USD20240223Open filing evidence

Revenue From Contract With Customer · Services · Markel Ventures

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31498290000 USD20240501Open filing evidence
2023-07-01 – 2023-09-30597512000 USD20231101Open filing evidence
2023-01-01 – 2023-09-301652187000 USD20231101Open filing evidence
2023-01-01 – 2023-03-31486481000 USD20240501Open filing evidence
2022-07-01 – 2022-09-30594717000 USD20231101Open filing evidence
2022-01-01 – 2022-09-301593946000 USD20231101Open filing evidence

Revenue From Contract With Customer · Services · Other Insurance Operations

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-312133000 USD20240501Open filing evidence
2023-01-01 – 2023-03-312854000 USD20240501Open filing evidence

Revenue From Contract With Customer · Services · Other

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-302415000 USD20240731Open filing evidence
2024-01-01 – 2024-06-304548000 USD20240731Open filing evidence
2023-07-01 – 2023-09-302904000 USD20231101Open filing evidence
2023-01-01 – 2023-09-307542000 USD20231101Open filing evidence
2023-04-01 – 2023-06-301784000 USD20240731Open filing evidence
2023-01-01 – 2023-06-304638000 USD20240731Open filing evidence
2022-07-01 – 2022-09-3011529000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3041547000 USD20231101Open filing evidence

Revenue From Contract With Customer · Product · Markel Ventures

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-31594592000 USD20240501Open filing evidence
2023-07-01 – 2023-09-30585707000 USD20231101Open filing evidence
2023-01-01 – 2023-09-301921773000 USD20231101Open filing evidence
2023-01-01 – 2023-03-31565895000 USD20240501Open filing evidence
2022-07-01 – 2022-09-30575277000 USD20231101Open filing evidence
2022-01-01 – 2022-09-301809276000 USD20231101Open filing evidence

Revenue From Contract With Customer · Product · Other

Concentration Risk By Benchmark · Product Or Service · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-310 USD20240223Open filing evidence
2023-07-01 – 2023-09-300 USD20231101Open filing evidence
2023-01-01 – 2023-09-300 USD20231101Open filing evidence
2022-01-01 – 2022-12-310 USD20240223Open filing evidence
2022-07-01 – 2022-09-300 USD20231101Open filing evidence
2022-01-01 – 2022-09-300 USD20231101Open filing evidence
2021-01-01 – 2021-12-310 USD20240223Open filing evidence

Revenue From Contract With Customer · Consumer And Other

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30277603000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-301072571000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-04-01 – 2026-06-30533060000 USD20260729Open filing evidence
2026-01-01 – 2026-06-30794968000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31261908000 USD20260428Open filing evidence
2025-01-01 – 2025-12-311311288000 USD20260226Open filing evidence
2025-07-01 – 2025-09-30273226000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-301054346000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-04-01 – 2025-06-30510919000 USD20260729Open filing evidence
2025-01-01 – 2025-06-30781120000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31270201000 USD20260428Open filing evidence
2024-01-01 – 2024-12-311259110000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30248328000 USD20251029Open filing evidence
2024-01-01 – 2024-09-301012909000 USD20251029Open filing evidence
2023-01-01 – 2023-12-311184035000 USD20260226Open filing evidence

Revenue From Contract With Customer · Consumer And Other · Management Fees

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Consumer And Other · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3097555000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-30280475000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-3091598000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-30258732000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Consumer And Other · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:ConsumerAndOtherMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30180048000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-30792096000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-30181628000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-30795614000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Corporate Operations

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-04-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-06-300 USD20260729Open filing evidence
2026-01-01 – 2026-03-310 USD20260428Open filing evidence
2025-01-01 – 2025-12-310 USD20260226Open filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-04-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-06-300 USD20260729Open filing evidence
2025-01-01 – 2025-03-310 USD20260428Open filing evidence
2024-01-01 – 2024-12-310 USD20260226Open filing evidence
2024-07-01 – 2024-09-300 USD20251029Open filing evidence
2024-01-01 – 2024-09-300 USD20251029Open filing evidence
2023-01-01 – 2023-12-310 USD20260226Open filing evidence

Revenue From Contract With Customer · Corporate Operations · Management Fees

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Corporate Operations · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Corporate Operations · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Financial

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3042273000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-30121855000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-04-01 – 2026-06-3037768000 USD20260729Open filing evidence
2026-01-01 – 2026-06-3079582000 USD20260729Open filing evidence
2026-01-01 – 2026-03-3141814000 USD20260428Open filing evidence
2025-01-01 – 2025-12-31163165000 USD20260226Open filing evidence
2025-07-01 – 2025-09-3030781000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-3086950000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-04-01 – 2025-06-3029831000 USD20260729Open filing evidence
2025-01-01 – 2025-06-3056169000 USD20260729Open filing evidence
2025-01-01 – 2025-03-3126338000 USD20260428Open filing evidence
2024-01-01 – 2024-12-3198054000 USD20260226Open filing evidence
2024-07-01 – 2024-09-3025506000 USD20251029Open filing evidence
2024-01-01 – 2024-09-3068816000 USD20251029Open filing evidence
2023-01-01 – 2023-12-31100325000 USD20260226Open filing evidence

Revenue From Contract With Customer · Financial · Management Fees

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3042198000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-30121410000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-3030340000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-3085790000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Financial · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-3075000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-30445000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-30441000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-301160000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Financial · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:FinancialMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Industrial

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-301130229000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-302976559000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-04-01 – 2026-06-30999577000 USD20260729Open filing evidence
2026-01-01 – 2026-06-301846330000 USD20260729Open filing evidence
2026-01-01 – 2026-03-31846753000 USD20260428Open filing evidence
2025-01-01 – 2025-12-313762841000 USD20260226Open filing evidence
2025-07-01 – 2025-09-301006134000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-302775935000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-04-01 – 2025-06-30977550000 USD20260729Open filing evidence
2025-01-01 – 2025-06-301769801000 USD20260729Open filing evidence
2025-01-01 – 2025-03-31792251000 USD20260428Open filing evidence
2024-01-01 – 2024-12-313664293000 USD20260226Open filing evidence
2024-07-01 – 2024-09-30968205000 USD20251029Open filing evidence
2024-01-01 – 2024-09-302707461000 USD20251029Open filing evidence
2023-01-01 – 2023-12-313565880000 USD20260226Open filing evidence

Revenue From Contract With Customer · Industrial · Management Fees

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Industrial · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30651348000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-301693728000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-30588148000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-301578137000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Industrial · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:IndustrialMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-30478881000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-301282831000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-30417986000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-301197798000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Markel Insurance

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-303136000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-306259000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-04-01 – 2026-06-301581000 USD20260729Open filing evidence
2026-01-01 – 2026-06-303123000 USD20260729Open filing evidence
2026-01-01 – 2026-03-311542000 USD20260428Open filing evidence
2025-01-01 – 2025-12-3110521000 USD20260226Open filing evidence
2025-07-01 – 2025-09-301199000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-304748000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-04-01 – 2025-06-301604000 USD20260729Open filing evidence
2025-01-01 – 2025-06-303549000 USD20260729Open filing evidence
2025-01-01 – 2025-03-311945000 USD20260428Open filing evidence
2024-01-01 – 2024-12-319365000 USD20260226Open filing evidence
2024-07-01 – 2024-09-302593000 USD20251029Open filing evidence
2024-01-01 – 2024-09-306313000 USD20251029Open filing evidence
2023-01-01 – 2023-12-319525000 USD20260226Open filing evidence

Revenue From Contract With Customer · Markel Insurance · Management Fees

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember;srt:ProductOrServiceAxis=mkl:ManagementFeesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Markel Insurance · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-303136000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-306259000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-301199000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-304748000 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Markel Insurance · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelInsuranceMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2026-07-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2026-01-01 – 2026-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-07-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence
2025-01-01 – 2025-09-300 USD2026-10-28 · 20:36:51.000ZOpen filing evidence

Revenue From Contract With Customer · Markel Ventures

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-301488469000 USD20250730Open filing evidence
2025-01-01 – 2025-06-302550921000 USD20250730Open filing evidence
2025-01-01 – 2025-03-311062452000 USD20250430Open filing evidence
2024-01-01 – 2024-12-314923403000 USD20250224Open filing evidence
2024-07-01 – 2024-09-301216533000 USD20241030Open filing evidence
2024-01-01 – 2024-09-303720370000 USD20241030Open filing evidence
2024-04-01 – 2024-06-301410955000 USD20250730Open filing evidence
2024-01-01 – 2024-06-302503837000 USD20250730Open filing evidence
2024-01-01 – 2024-03-311092882000 USD20250430Open filing evidence
2023-01-01 – 2023-12-314749915000 USD20250224Open filing evidence
2023-07-01 – 2023-09-301181166000 RestatedUSD20241030Open filing evidence
2023-01-01 – 2023-09-303573112000 RestatedUSD20241030Open filing evidence
2023-04-01 – 2023-06-301339570000 USD20240731Open filing evidence
2023-01-01 – 2023-06-302391946000 USD20240731Open filing evidence
2023-01-01 – 2023-03-311052376000 USD20240501Open filing evidence
2022-01-01 – 2022-12-314563595000 USD20250224Open filing evidence
2022-07-01 – 2022-09-301169994000 USD20231101Open filing evidence
2022-01-01 – 2022-09-303403222000 USD20231101Open filing evidence

Revenue From Contract With Customer · Markel Ventures · Investment Management

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-300 USD20240731Open filing evidence
2024-01-01 – 2024-06-300 USD20240731Open filing evidence
2023-07-01 – 2023-09-300 USD20231101Open filing evidence
2023-01-01 – 2023-09-300 USD20231101Open filing evidence
2023-04-01 – 2023-06-300 USD20240731Open filing evidence
2023-01-01 – 2023-06-300 USD20240731Open filing evidence
2022-07-01 – 2022-09-300 USD20231101Open filing evidence
2022-01-01 – 2022-09-300 USD20231101Open filing evidence

Revenue From Contract With Customer · Markel Ventures · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2024-04-01 – 2024-06-30570319000 USD20240731Open filing evidence
2024-01-01 – 2024-06-301068609000 USD20240731Open filing evidence
2023-04-01 – 2023-06-30569399000 USD20240731Open filing evidence
2023-01-01 – 2023-06-301055880000 USD20240731Open filing evidence

Revenue From Contract With Customer · Markel Ventures Operations

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-301189796000 USD20221101Open filing evidence
2022-01-01 – 2022-09-303442629000 USD20221101Open filing evidence
2022-04-01 – 2022-06-301333928000 USD20220802Open filing evidence
2022-01-01 – 2022-06-302252833000 USD20220802Open filing evidence
2021-01-01 – 2021-12-313532154000 USD20220218Open filing evidence

Revenue From Contract With Customer · Markel Ventures Operations · Investment Management

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember
PeriodValueUnitFiledEvidence
2022-04-01 – 2022-06-300 USD20220802Open filing evidence
2022-01-01 – 2022-06-300 USD20220802Open filing evidence
2021-01-01 – 2021-12-310 USD20220218Open filing evidence

Revenue From Contract With Customer · Markel Ventures Operations · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-311863706000 USD20220218Open filing evidence

Revenue From Contract With Customer · Markel Ventures Operations · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-30575277000 USD20221101Open filing evidence
2022-01-01 – 2022-09-301809276000 USD20221101Open filing evidence
2022-04-01 – 2022-06-30764543000 USD20220802Open filing evidence
2022-01-01 – 2022-06-301233999000 USD20220802Open filing evidence
2021-01-01 – 2021-12-311668448000 USD20220218Open filing evidence

Revenue From Contract With Customer · Other Insurance Operations

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-3122069000 USD20240501Open filing evidence
2023-01-01 – 2023-03-3113313000 USD20240501Open filing evidence

Revenue From Contract With Customer · Other Insurance Operations · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-03-310 USD20240501Open filing evidence
2023-01-01 – 2023-03-310 USD20240501Open filing evidence

Revenue From Contract With Customer · Other

Concentration Risk By Benchmark · Statement Business Segments

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2025-04-01 – 2025-06-3031435000 USD20250730Open filing evidence
2025-01-01 – 2025-06-3059718000 USD20250730Open filing evidence
2025-01-01 – 2025-03-3128283000 USD20250430Open filing evidence
2024-01-01 – 2024-12-31107419000 USD20250224Open filing evidence
2024-07-01 – 2024-09-3028099000 USD20241030Open filing evidence
2024-01-01 – 2024-09-3075129000 USD20241030Open filing evidence
2024-04-01 – 2024-06-3024961000 USD20250730Open filing evidence
2024-01-01 – 2024-06-3047030000 USD20250730Open filing evidence
2024-01-01 – 2024-03-3122069000 USD20250430Open filing evidence
2023-01-01 – 2023-12-31109850000 USD20250224Open filing evidence
2023-07-01 – 2023-09-3047108000 USD20241030Open filing evidence
2023-01-01 – 2023-09-3083650000 USD20241030Open filing evidence
2023-04-01 – 2023-06-3023229000 USD20240731Open filing evidence
2023-01-01 – 2023-06-3036542000 USD20240731Open filing evidence
2023-01-01 – 2023-03-3113313000 USD20230426Open filing evidence
2022-01-01 – 2022-12-31123084000 USD20250224Open filing evidence
2022-07-01 – 2022-09-3027170000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3096744000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3028778000 USD20220802Open filing evidence
2022-01-01 – 2022-06-3069574000 USD20220802Open filing evidence
2022-01-01 – 2022-03-3140796000 USD20230426Open filing evidence
2021-01-01 – 2021-12-31221107000 USD20240223Open filing evidence

Revenue From Contract With Customer · Other · Investment Management

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3044204000 USD20231101Open filing evidence
2023-01-01 – 2023-09-3076108000 USD20231101Open filing evidence
2022-07-01 – 2022-09-3015641000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3055197000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3020328000 USD20220802Open filing evidence
2022-01-01 – 2022-06-3039556000 USD20220802Open filing evidence
2021-01-01 – 2021-12-3186257000 USD20220218Open filing evidence

Revenue From Contract With Customer · Other · Services

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2021-01-01 – 2021-12-31134850000 USD20220218Open filing evidence

Revenue From Contract With Customer · Other · Product

Concentration Risk By Benchmark · Statement Business Segments · Product Or Service

Source dimensions us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-03-310 USD20230426Open filing evidence
2022-04-01 – 2022-06-300 USD20220802Open filing evidence
2022-01-01 – 2022-06-300 USD20220802Open filing evidence
2022-01-01 – 2022-03-310 USD20230426Open filing evidence
2021-01-01 – 2021-12-310 USD20220218Open filing evidence

Corporate Expense

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:CorporateExpenseMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-310 USD20250224Open filing evidence
2023-01-01 – 2023-12-310 USD20250224Open filing evidence
2022-01-01 – 2022-12-310 USD20250224Open filing evidence

Insurance

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:InsuranceMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-317407643000 USD20250224Open filing evidence
2023-01-01 – 2023-12-317282705000 USD20250224Open filing evidence
2022-01-01 – 2022-12-316528263000 USD20250224Open filing evidence
2021-01-01 – 2021-12-315465284000 USD20240223Open filing evidence

Investing

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:InvestingMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-312772950000 USD20250224Open filing evidence
2023-01-01 – 2023-12-312241419000 USD20250224Open filing evidence
2022-01-01 – 2022-12-31-1167548000 USD20250224Open filing evidence
2021-01-01 – 2021-12-312353124000 USD20240223Open filing evidence

Markel Ventures

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-315120096000 USD20250224Open filing evidence
2023-01-01 – 2023-12-314985081000 USD20250224Open filing evidence
2023-07-01 – 2023-09-301245577000 USD20231101Open filing evidence
2023-01-01 – 2023-09-303735329000 USD20231101Open filing evidence
2023-04-01 – 2023-06-301385813000 USD20230802Open filing evidence
2023-01-01 – 2023-06-302489752000 USD20230802Open filing evidence
2023-01-01 – 2023-03-311103939000 USD20230426Open filing evidence
2022-01-01 – 2022-12-314757527000 RestatedUSD20250224Open filing evidence
2022-07-01 – 2022-09-301215746000 USD20231101Open filing evidence
2022-01-01 – 2022-09-303527429000 USD20231101Open filing evidence
2022-04-01 – 2022-06-301361298000 USD20230802Open filing evidence
2022-01-01 – 2022-06-302311683000 USD20230802Open filing evidence
2022-01-01 – 2022-03-31950385000 USD20230426Open filing evidence
2021-01-01 – 2021-12-313643827000 RestatedUSD20240223Open filing evidence

Markel Ventures · Disposition Gain

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:DispositionGainMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-300 USD20230802Open filing evidence
2023-01-01 – 2023-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-12-310 USD20230217Open filing evidence
2022-04-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-06-300 USD20230802Open filing evidence
2021-01-01 – 2021-12-310 USD20230217Open filing evidence

Markel Ventures · Investment Management · Revenue From Contract With Customer

Statement Business Segments · Product Or Service · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-300 USD20230802Open filing evidence
2023-01-01 – 2023-06-300 USD20230802Open filing evidence
2023-01-01 – 2023-03-310 USD20230426Open filing evidence
2022-04-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-03-310 USD20230426Open filing evidence

Markel Ventures · Other Revenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:OtherRevenuesMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-3062379000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30160282000 USD20231101Open filing evidence
2023-04-01 – 2023-06-3047016000 USD20230802Open filing evidence
2023-01-01 – 2023-06-3097903000 USD20230802Open filing evidence
2023-01-01 – 2023-03-3150887000 USD20230426Open filing evidence
2022-01-01 – 2022-12-31111806000 USD20230217Open filing evidence
2022-07-01 – 2022-09-3046298000 USD20231101Open filing evidence
2022-01-01 – 2022-09-30122670000 USD20231101Open filing evidence
2022-04-01 – 2022-06-3036134000 USD20230802Open filing evidence
2022-01-01 – 2022-06-3076372000 USD20230802Open filing evidence
2022-01-01 – 2022-03-3128422000 USD20230426Open filing evidence
2021-01-01 – 2021-12-31111662000 USD20230217Open filing evidence

Markel Ventures · Program Services And Other Fronting

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-300 USD20230802Open filing evidence
2023-01-01 – 2023-06-300 USD20230802Open filing evidence
2023-01-01 – 2023-03-310 USD20230426Open filing evidence
2022-01-01 – 2022-12-310 USD20230217Open filing evidence
2022-04-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-03-310 USD20230426Open filing evidence
2021-01-01 – 2021-12-310 USD20230217Open filing evidence

Markel Ventures · Services · Revenue From Contract With Customer

Statement Business Segments · Product Or Service · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=mkl:ServicesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30569013000 USD20230802Open filing evidence
2023-01-01 – 2023-06-301054675000 USD20230802Open filing evidence
2022-04-01 – 2022-06-30561596000 USD20230802Open filing evidence
2022-01-01 – 2022-06-30999229000 USD20230802Open filing evidence

Markel Ventures · Product · Revenue From Contract With Customer

Statement Business Segments · Product Or Service · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-30770171000 USD20230802Open filing evidence
2023-01-01 – 2023-06-301336066000 USD20230802Open filing evidence
2022-01-01 – 2022-12-312379399000 USD20230217Open filing evidence
2022-04-01 – 2022-06-30764543000 USD20230802Open filing evidence
2022-01-01 – 2022-06-301233999000 USD20230802Open filing evidence
2021-01-01 – 2021-12-311668448000 USD20230217Open filing evidence

Markel Ventures · Revenue From Contract With Customer

Statement Business Segments · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-314749915000 USD20240223Open filing evidence
2023-04-01 – 2023-06-301339184000 USD20230802Open filing evidence
2023-01-01 – 2023-06-302390741000 USD20230802Open filing evidence
2023-01-01 – 2023-03-311051557000 USD20230426Open filing evidence
2022-01-01 – 2022-12-314563595000 RestatedUSD20240223Open filing evidence
2022-04-01 – 2022-06-301326139000 USD20230802Open filing evidence
2022-01-01 – 2022-06-302233228000 USD20230802Open filing evidence
2022-01-01 – 2022-03-31918905000 USD20230426Open filing evidence
2021-01-01 – 2021-12-313505477000 RestatedUSD20240223Open filing evidence

Markel Ventures · Revenue From Contract With Customer · Investment Management

Statement Business Segments · Concentration Risk By Benchmark · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-310 USD20240223Open filing evidence
2022-01-01 – 2022-12-310 USD20240223Open filing evidence
2021-01-01 – 2021-12-310 USD20240223Open filing evidence

Markel Ventures · Revenue From Contract With Customer · Services

Statement Business Segments · Concentration Risk By Benchmark · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-312265413000 USD20230217Open filing evidence
2021-01-01 – 2021-12-311863706000 USD20230217Open filing evidence

Markel Ventures · Revenue From Contract With Customer · Product

Statement Business Segments · Concentration Risk By Benchmark · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=us-gaap:ProductMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-312487054000 USD20240223Open filing evidence
2023-01-01 – 2023-03-31565895000 USD20230426Open filing evidence
2022-01-01 – 2022-12-312379399000 USD20240223Open filing evidence
2022-01-01 – 2022-03-31469456000 USD20230426Open filing evidence
2021-01-01 – 2021-12-311668448000 USD20240223Open filing evidence

Markel Ventures Operations

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-301215746000 USD20221101Open filing evidence
2022-01-01 – 2022-09-303527429000 USD20221101Open filing evidence
2022-04-01 – 2022-06-301361298000 USD20220802Open filing evidence
2022-01-01 – 2022-06-302311683000 USD20220802Open filing evidence
2022-01-01 – 2022-03-31950385000 USD20220426Open filing evidence
2021-01-01 – 2021-12-313643816000 USD20220218Open filing evidence

Markel Ventures Operations · Disposition Gain

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:DispositionGainMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-09-300 USD20221101Open filing evidence
2022-01-01 – 2022-03-310 USD20220426Open filing evidence

Markel Ventures Operations · Other Revenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:OtherRevenuesMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-3131480000 USD20220426Open filing evidence
2021-01-01 – 2021-12-31111662000 USD20220218Open filing evidence

Markel Ventures Operations · Program Services And Other Fronting

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember
PeriodValueUnitFiledEvidence
2022-07-01 – 2022-09-300 USD20221101Open filing evidence
2022-01-01 – 2022-09-300 USD20221101Open filing evidence
2022-01-01 – 2022-03-310 USD20220426Open filing evidence

Markel Ventures Operations · Product · Revenue From Contract With Customer

Statement Business Segments · Product Or Service · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-31469456000 USD20220426Open filing evidence

Markel Ventures Operations · Revenue From Contract With Customer

Statement Business Segments · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:MarkelVenturesOperationsMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-03-31918905000 USD20220426Open filing evidence

Other Insurance Operations

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherInsuranceOperationsMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-31291873000 USD20250224Open filing evidence
2023-01-01 – 2023-12-31280131000 USD20250224Open filing evidence
2022-01-01 – 2022-12-31493746000 USD20250224Open filing evidence

Other

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-31280131000 USD20240223Open filing evidence
2023-07-01 – 2023-09-3081574000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30192782000 USD20231101Open filing evidence
2023-04-01 – 2023-06-3071360000 USD20230802Open filing evidence
2023-01-01 – 2023-06-30111208000 USD20230802Open filing evidence
2023-01-01 – 2023-03-3139848000 USD20230426Open filing evidence
2022-01-01 – 2022-12-31493746000 RestatedUSD20240223Open filing evidence
2022-07-01 – 2022-09-3062438000 RestatedUSD20231101Open filing evidence
2022-01-01 – 2022-09-30280267000 RestatedUSD20231101Open filing evidence
2022-04-01 – 2022-06-3055653000 RestatedUSD20230802Open filing evidence
2022-01-01 – 2022-06-30217829000 RestatedUSD20230802Open filing evidence
2022-01-01 – 2022-03-31162176000 RestatedUSD20230426Open filing evidence
2021-01-01 – 2021-12-31342142000 RestatedUSD20240223Open filing evidence

Other · Investment Management · Revenue From Contract With Customer

Statement Business Segments · Product Or Service · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-3021445000 USD20230802Open filing evidence
2023-01-01 – 2023-06-3031904000 USD20230802Open filing evidence
2022-04-01 – 2022-06-3020328000 USD20230802Open filing evidence
2022-01-01 – 2022-06-3039556000 USD20230802Open filing evidence

Other · Other Revenues

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:OtherRevenuesMember
PeriodValueUnitFiledEvidence
2023-07-01 – 2023-09-30-9297000 USD20231101Open filing evidence
2023-01-01 – 2023-09-30-12258000 USD20231101Open filing evidence
2023-04-01 – 2023-06-30407000 USD20230802Open filing evidence
2023-01-01 – 2023-06-301065000 USD20230802Open filing evidence
2022-01-01 – 2022-12-31-16621000 USD20230217Open filing evidence
2022-07-01 – 2022-09-301790000 USD20231101Open filing evidence
2022-01-01 – 2022-09-3010773000 USD20231101Open filing evidence
2022-04-01 – 2022-06-30391000 USD20230802Open filing evidence
2022-01-01 – 2022-06-307392000 USD20230802Open filing evidence
2021-01-01 – 2021-12-318699000 RestatedUSD20230217Open filing evidence

Other · Program Services And Other Fronting

Statement Business Segments · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=mkl:ProgramServicesAndOtherFrontingMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-3037563000 USD20230802Open filing evidence
2023-01-01 – 2023-06-3066453000 USD20230802Open filing evidence
2022-01-01 – 2022-12-31147612000 USD20230217Open filing evidence
2022-04-01 – 2022-06-3029731000 USD20230802Open filing evidence
2022-01-01 – 2022-06-3063063000 USD20230802Open filing evidence
2021-01-01 – 2021-12-31123823000 USD20230217Open filing evidence

Other · Product · Revenue From Contract With Customer

Statement Business Segments · Product Or Service · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;srt:ProductOrServiceAxis=us-gaap:ProductMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-300 USD20230802Open filing evidence
2023-01-01 – 2023-06-300 USD20230802Open filing evidence
2022-04-01 – 2022-06-300 USD20230802Open filing evidence
2022-01-01 – 2022-06-300 USD20230802Open filing evidence

Other · Revenue From Contract With Customer

Statement Business Segments · Concentration Risk By Benchmark

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember
PeriodValueUnitFiledEvidence
2023-04-01 – 2023-06-3023229000 USD20230802Open filing evidence
2023-01-01 – 2023-06-3036542000 USD20230802Open filing evidence
2022-01-01 – 2022-12-31123084000 USD20230217Open filing evidence
2022-04-01 – 2022-06-3028778000 USD20230802Open filing evidence
2022-01-01 – 2022-06-3069574000 USD20230802Open filing evidence
2021-01-01 – 2021-12-31221107000 USD20230217Open filing evidence

Other · Revenue From Contract With Customer · Investment Management

Statement Business Segments · Concentration Risk By Benchmark · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:InvestmentManagementMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-3179209000 USD20230217Open filing evidence
2021-01-01 – 2021-12-3186257000 USD20230217Open filing evidence

Other · Revenue From Contract With Customer · Services

Statement Business Segments · Concentration Risk By Benchmark · Product Or Service

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:OtherMember;us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:RevenueFromContractWithCustomerMember;srt:ProductOrServiceAxis=mkl:ServicesMember
PeriodValueUnitFiledEvidence
2022-01-01 – 2022-12-3143875000 USD20230217Open filing evidence
2021-01-01 – 2021-12-31134850000 USD20230217Open filing evidence

Reinsurance

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=mkl:ReinsuranceMember
PeriodValueUnitFiledEvidence
2024-01-01 – 2024-12-311028201000 USD20250224Open filing evidence
2023-01-01 – 2023-12-311014294000 USD20250224Open filing evidence
2022-01-01 – 2022-12-311063347000 USD20250224Open filing evidence
2021-01-01 – 2021-12-311042048000 USD20240223Open filing evidence